Public health guidance on active case finding of communicable diseases in prison settings
This joint guidance from ECDC and the European Monitoring Centre for Drugs and Drug Addiction provides EU/EEA Member States with evidence-based scientific advice on active case finding options. These options can be applied to the planning and implementation of interventions that promote the early diagnosis of communicable diseases in prison settings.
Systematic review on active case finding of communicable diseases in prison settings
The objective of this report is to systematically review the evidence on active case finding in prison settings, with a focus on the European Union (EU) and the European Economic Area (EEA) region.
Technical mission: HIV, STI and viral hepatitis in Bulgaria. 19-21 September 2016 and 14-15 November 2016
The Ministry of Health in Bulgaria invited ECDC to prepare an assessment of the current national HIV programme and to review the STI and Hepatitis surveillance system. Following discussions between ECDC and representatives of the Bulgarian national programme, it was decided to split the assessment into two separate country missions.
Late presentation of chronic viral hepatitis for medical care: A consensus definition
Mauss, S., Pol, S., Buti, M., Duffell, E., Gore, C., Lazarus, J.V., van der Grient, H.L., Lundgren, J., Mozalevskis, A., Raben, D., Schatz, E., Wiktor, S., Rockstroh, J.K., Veldhuijzen, I., Dedes, N., Gatell, J., West, B., Casabona, J.
Systematic review on hepatitis B and C prevalence in the EU/EEA
ECDC conducted a systematic review of the literature published between 2005–2015, with the aim to estimate the prevalence of hepatitis B and C in the general population and specific population subgroups in the EU/EEA Member States. This review is an update of an earlier review covering the period 2000–2009.
Communication strategies for the prevention of HIV, STI and hepatitis among MSM in Europe
This document provides guidance for developing innovative and effective communication strategies to promote a culture of lower risk behaviour in the MSM community in the European Union and European Economic Area.
Hepatitis A virus in the EU/EEA, 1975–2014
A systematic review of seroprevalence and incidence comprising European surveillance data and national vaccination recommendations. This report provides a comprehensive picture of Hepatitis A virus (HAV) infection epidemiology in the EU/EEA between 1975 and 2014.